Mark Stolper insider trades
Open-market stock purchases and sales by Mark Stolper, Director at Oncology Institute, Inc, from SEC Form 4 filings since Apr 26, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +268%.
Companies traded
- TOI Oncology Institute, Inc: other filings, last Jul 27, 2026
- RDNT RadNet, Inc: 12 sales, last Mar 3, 2026
- CHRS Coherus BioSciences, Inc: other filings, last Jun 3, 2024
- SRGA Surgalign Holdings, Inc: 1 buy, last Aug 15, 2022
- RTIX RTI Surgical Holdings, Inc: 1 buy, last Feb 26, 2020
- OTIV ON Track Innovations Ltd: other filings, last May 26, 2014
- HSON Hudson Global, Inc: 1 buy, last Aug 29, 2013
- MDF Metropolitan Health Networks Inc: other filings, last Dec 21, 2012